CHA2 DS2-VASc 评分对初发心源性卒中预后判断的应用研究
Journal of Chinese Physician(2014)
Abstract
目的:研究CHA2DS2-VASc[congestive heart failure,hypertension,age≥75y(doubled),diabetes mellitus,stroke (doubled)-vascular disease,age 65~74 and sex category(female)]评分与合并心房颤动的初发心源性卒中预后之间的关系。方法收集346例初发心源性卒中患者的相关临床资料,起病时的美国卫生研究院卒中量表( National Institutes of Health Stroke Scale,NIHSS)评分以及90 d时改良Rankin量表( modified Rankin Scale ,mRS)评分和CHA2 DS2-VASc评分,并对其进行分析。结果年龄、性别(女性)、吸烟史、高血压病史、充血性心衰病史、既往抗凝治疗史、入院时NHISS评分和CHA2 DS2-VASc评分在不同预后组中差异有统计学意义( P <0.05)。 CHA2DS2-VASc评分与NIHSS评分(ρ=0.324, P <0.01),mRS评分(ρ=0.228, P <0.01)呈正相关,多因素Logistic逐步回归分析显示年龄、吸烟、抗凝治疗、CHA2 DS2-VASc评分、NIHSS评分是预测初发心源性卒中预后的独立因素。结论 CHA2 DS2-VASc评分不仅能够用于心房颤动患者卒中风险分层,而且还能预测卒中合并房颤患者的预后。
MoreTranslated text
Key words
initial cardioembolic stroke,fi-brillation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined